Molecular & Cellular Proteomics
ResearchUrinary Proteomic Biomarkers in Coronary Artery Disease*
Cited by (0)
Published, MCP Papers in Press, October 19, 2007, DOI 10.1074/mcp.M700394-MCP200
- *
This work was supported in part by the British Heart Foundation Chair and Programme Grant BHF PG/02/128, Wellcome Trust Cardiovascular Functional Genomics Initiative 066780/2/012, and European Union InGenious HyperCare Grant LSHM-CT-2006-037093 (to A. F. D. and H. M.); by the Joint Infrastructure Fund funding for the Sir Henry Wellcome Functional Genomics Facility; and by the Biotechnology and Biological Sciences Research Council and Engineering and Physical Sciences Research Council Radical Solutions for Researching the Proteome (RASOR) grant. H. Mischak is founder and co-owner of Mosaiques Diagnostics, which developed the CE-MS technology and the MosaiquesVisu software. E. Schiffer and P. Zürbig are employees of Mosaiques Diagnostics. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.mcponline.org) contains supplemental material.
- b
Both authors contributed equally to this work.
- c
Supported by Swiss National Science Foundation Grant PBBSB-105860 and the Lichtenstein-Stiftung, Basel, Switzerland. Present address: Medical Outpatient Dept., University Hospital, CH-8091 Zurich, Switzerland.
- f
Supported by a National Institutes of Health predoctoral fellowship (Biotechnology Training Program Grant NIH 5T32GM08349).
- l
Supported by a personal fellowship from the Deutsche Forschungsgemeinschaft (Grant DE 826/1-1).